-
Mashup Score: 4News: Genome Editing With Cas9 and AAV Generates Frequent Insertion of Viral Vectors That Are Difficult to Detect - CRISPR Medicine - 4 day(s) ago
Researchers in the US, Japan and the UK report in Nature Biotechnology that genome editing with Cas9 and adeno-associated virus repair templates leads to frequent insertion of viral vectors that are difficult to detect.
Source: crisprmedicinenews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 22Perfume from Extinct Flowers, Thanks to Ancient DNA and Synthetic Biology - DNA Science - 6 day(s) ago
“Enchant your loved ones with nature’s lost scents, revived through biotechnology and perfume artistry.” When that popped up on Facebook, I was…
Source: dnascience.plos.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 3Former bluebird execs hope to fly new startup to 'cutting edge' of gene therapy delivery tech - 7 day(s) ago
The untapped potential of gene editing therapies comes down to one major challenge: getting gene editors safely and efficiently into cells. | The untapped potential of gene editing therapies comes down to one major challenge: getting gene editors safely and efficiently into cells. Now, a new startup founded by two genetic medicine luminaries and run by former executives from bluebird bio is officially emerging from stealth mode to reveal its solutions to the industry.
Source: www.fiercebiotech.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 3Finally, a safe vegan leather to 'Dye' for - 9 day(s) ago
This is a clear case of using biology as a solution to — and a healthier and safe alternative to — the environmentally toxic process of synthetic chemical dyein
Source: www.newindianexpress.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 23Plastic-free vegan leather that dyes itself grown from bacteria | Imperial News | Imperial College London - 16 day(s) ago
FUTURE FASHION – Researchers at Imperial College London have genetically engineered bacteria to grow animal- and plastic-free leather that dyes itself.
Source: www.imperial.ac.ukCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 21
A recent study conducted by researchers at the Broad Institute of MIT and Harvard and MIT in the US has found that adding multiple “tails” to the new Messenger RNA (mRNA) structure can enhance its efficiency in cells by five to 20 times. mRNA, known for its role in Covid-19 vaccines, is being explored for […]
Source: www.uniquenewsonline.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 26
Scientists have engineered long lasting mRNAs that increased therapeutic protein production in cells and animals.
Source: www.broadinstitute.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 4
The team behind the first AI-designed drug to hit Phase II clinical trials have now published a paper on how they developed it so fast.
Source: singularityhub.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 22IICD Researchers Introduce Starfysh, a Breakthrough Tool Transforming Spatial Gene Expression Analysis | Columbia University - 28 day(s) ago
IICD researcher Elham Azizi – Herbert and Florence Irving Assistant Professor of Cancer Data Research and Assistant Professor of Biomedical Engineering – and her team introduce an innovative computational tool named Starfysh, designed to revolutionize the study of gene expression within tissues. This breakthrough has far-reaching implications because cells in our bodies can behave differently depending on their context and surroundings, and characterizing these differences can help us understand tissue
Source: cancerdynamics.columbia.eduCategories: General Medicine News, Future of MedicineTweet-
@ColumbiaBME @Cancer_dynamics @UCSF @MSKCancerCenter @GradSchoolSinai @WashUBME @elhamazizi @SiyuHe7 @YinuoJin6 @AchilleNazaret IICD researchers introduce Starfysh, a breakthrough tool transforming spatial gene expression analysis #NBTintheNews via @Cancer_dynamics https://t.co/8kLv6Ao6Lh https://t.co/GuKoJouVFY
-
-
Mashup Score: 4
The team behind the first AI-designed drug to hit Phase II clinical trials have now published a paper on how they developed it so fast.
Source: singularityhub.comCategories: General Medicine News, Future of MedicineTweet
Genome editing with Cas9 and AAV generates frequent insertion of viral vectors that are difficult to detect #NBTintheNews https://t.co/lgbDKL62SW